Laboratory Filtration Market by Product (Filtration Assembly, Filter Media Accessories), Technology (Ultrafiltration, Microfiltration, Nanofiltration, RO), End User (Pharmaceutical, Biopharmaceutical Company, F&B), Region – Global Forecast to 2025

2020-01-10
Price :
Published : Jan-2020
No. of Pages : 221

“Rising demand for lab filters from pharmaceutical & biotechnology companies to drive market growth”

The global laboratory filtration market is projected to reach USD 4.1 billion by 2025 from USD 2.5 billion in 2019, at a CAGR of 8.3%. Growth in this market is majorly driven by the growing demand for membrane filtration technology, increasing manufacturing of biosimilars, and the growing focus on developing large-molecule biopharmaceuticals.

“The filtration media segment will register the highest growth in the market, by product”

Based on product, the market is segmented into filtration media (filter papers, membrane filters, syringe and syringeless filters, filtration microplates, and other filtration media), filtration assemblies (microfiltration assemblies, reverse osmosis assemblies, ultrafiltration assemblies, vacuum filtration assemblies, and other filtration assemblies), and filtration accessories (filter holders, filter funnels, filter flasks, membrane dispensers, filter housings, cartridges, vacuum pumps, seals, and other filtration accessories). The filtration media segment is expected to witness the highest CAGR in the laboratory filtration market during the forecast period. The large share of this segment can be attributed to the high usage of filtration media in different industries like the food &beverage industry. Their high usage and the need for repeat purchases equate to a larger market share and higher growth rate.

“Microfiltration testing is the largest technique segment of the lab filtration industry”

Based on technique, the market is segmented into microfiltration, ultrafiltration, reverse osmosis, vacuum filtration, and nanofiltration. In 2018, the microfiltration segment accounted for the largest share of the laboratory filtration market. This can be attributed to the increasing use of microfiltration membranes as a prefilter to ultrafiltration and reverse osmosis and rising pharmaceutical and biologics R&D.

“North America will continue to dominate the laboratory filtration market during the forecast period”

By region, the market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the laboratory filtration market. The large share of North America can be attributed to increasing health and environment concerns, which, in turn, has led to the formulation of stringent legislations regarding the quality of culture media and reagent-grade. Moreover, increasing research on the development of drugs will also boost demand, thereby driving regional growth over the forecast period.

The breakup of primary participants is as mentioned below:

  • By Company Type: Tier 1:45%; Tier 2: 30%; and Tier 3: 25%
  • By Designation: C-level: 35%; Director-level: 25%;and Others: 40%
  • By Region: North America: 40%;Europe: 20%;Asia Pacific: 25%;Latin America: 10%;and the Middle East & Africa: 5%

The prominent players in the global laboratory filtration market are Merck Millipore (US), Danaher Corporation (US), Sartorius Ag (Germany), 3M Company (US), GE Healthcare (US), GEA GROUP AKTIENGESELLSCHAFT (Germany), Cantel Medical Corporation (US), Thermo Fisher Scientific (US), Veolia Water Technologies (France), Avantor, Inc (US), GVS S.p.A (Italy), MANN+HUMMEL (Germany), Agilent Technologies, Inc (US), Ahlstrom-Munksjö (Finland), MACHEREY-NAGEL GmbH & Co. KG (Germany), AMD Manufacturing, Inc. (Canada), Koch Membrane Systems (US), Cole-Parmer (US), AQUAPORIN A/S (Denmark), and Sterlitech Corporation (US).

Research Coverage:

The report analyzes the laboratory filtration market and aims at estimating the market size and future growth potential of this market based on various segments such as product, technique, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights into:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the laboratory filtration market. The report analyzes this market by product, technique, end user, and region.
  • Market Development: Comprehensive information on the lucrative emerging markets by product, technique, end user, and region.
  • Market Diversification: Exhaustive information about products, growing geographies, recent developments, and investments in the laboratory filtration market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the laboratory filtration market.
Filed in: Biotechnology
Publisher : marketsandmarkets
More Reports
Title Price Buy Now

Animal Growth Promoters and Performance Enhancers Market by Product Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probioitcs & Prebiotics, Phytogenics), Animal (Poultry, Porcine, Livestock, Aquaculture) – Global Forecast to 2024

“The animal growth promoters and performance enhancers market projected to grow at a CAGR of 5.9% during the forecast period (2019–2024).” The global animal growth promoters and performance enhancers market is projected to reach USD 18.5 billion by 2024 from an estimated USD 13.9 billion in 2019, at a CAGR of 5.9%during the forecast period. The key factors driving the growth of this market is the increasing global meat demand, research into alternatives to antibiotics, and the need to deal with epidemics and environmental factors. However, various countries have stringent regulations in place against antibiotics and particular growth promoters, which has affected their adoption. “By type, the non-antibiotic growth promoters segment is expected to grow at the highest CAGR duri......
$5650

Gene Therapy Market by Vectors [Non-viral (Oligonucleotides), Viral (Retroviral (Gammaretroviral, Lentiviral)), Adeno-associated], Indication (Cancer, Neurological Diseases), Delivery Method (In Vivo, Ex Vivo), Region – Global Forecast to 2024

“High incidence of cancer& other target diseases is a major factor driving the growth of the gene therapy market” The global gene therapy market is projected to reach USD 13.0 billion by 2024 from USD 3.8 billion in 2019, at a CAGR of 27.8% during the forecast period. The high incidence of cancer and other target diseases, availability of reimbursement, and the launch of new products are the major factors driving the growth of this market. In addition, the strong product pipeline of market players is expected to offer significant growth opportunities in the coming years. However, the high cost of treatment is expected to hamper market growth to a certain extent in the coming years. “Neurological diseases segment accounted for the largest share of the gene therapy market, by......
$5650

Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents, Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Laboratories, Pharma-Biotech Cos), Application – Global Forecasts to 2025

“The global flow cytometry market is projected to grow at a CAGR of 8.3%.” The global flow cytometry market size is projected to reach USD 6.4 billion by 2025 from USD 4.0 billion in 2019, growing at a CAGR of 8.3% from 2019 to 2025. The key factors driving the growth of this market include technological advancements in flow cytometers, the increasing adoption of flow cytometry in research and clinical trials, growing focus on immunology and immuno-oncology research, increasing incorporation of AI platforms in flow cytometry workflows and advancements in flow cytometry software, high incidence and prevalence of target diseases, and the availability of novel products. “The bead-based technology segment is expected to grow at the fastest rate during the forecast period.” By ......
$5650

Isothermal Nucleic Acid Amplification Technology/INAAT Market by Product (Assay & Kit, System), Application (Infectious disease [HIV, Influenza], Blood Screening), Type (LAMP, SDA, NASBA, HDA), End User, Region – Global Forecast to 2024

“The rising prevalence of infectious diseases and the introduction of newer pathogens, and the cost-benefits of INAAT is expected to drive the overall growth of the INAAT market” The global isothermal nucleic acid amplification technology (INAAT) market size is expected to grow from USD 1.9 billion in 2019to USD 3.3 billion by 2024, at a CAGR of 11.0% during the forecast period. The major factors driving the growth of this market include the rising prevalence of infectious diseases and the introduction of newer pathogens, the need for prompt diagnosis, the increasing number of blood transfusions and donations, and the cost-benefits of INAAT. However, the extensive usage and reliance on PCR are expected to limit the adoption of INAAT. “Assay, kits and reagents segment is expecte......
$4950

Tangential Flow Filtration Market by Product (TFF System, Membrane Filter), Application (Bioprocess, Viral Vector Purification), Technique (Ultrafiltration, Microfiltration), Material Type (PES/PS Membrane), Region – Global Forecast to 2024

“Advantages of tangential flow filtration over normal flow filtration (NFF) are expected to drive the overall growth of the tangential flow filtration market.” The tangential flow filtration market is expected to grow from USD 944 million in 2019 to USD 1,590 million by 2024, at a CAGR of 11.0% during the forecast period. The major factors driving the growth of this market include the advantages of tangential flow filtration (TFF) over normal flow filtration (NFF), increasing adoption of single-use technologies, and increased cGMP adoption. However, the high capital expenditure required to set up new production facilities is a major factor restraining the growth of this market. “The membrane filter segment is expected to grow at the highest CAGR during the forecast period.” ......
$5650

Biotechnology – Thematic Research

Biotechnology - Thematic Research Summary At its core, biotechnology is harnessing biological and molecular systems to develop products and processes. This report focuses on the most important and fastest growing areas of biotechnology which are its application to health and medicine. It is divided into three areas: agricultural biotechnology, which includes development of genetically modified crops; industrial biotechnology, which includes production of chemicals, paper and textiles; and medical biotechnology which includes the themes covered in this report such as biosimilars and the microbiome. The thematic report also predicts that companies which make the most effective use of the modern data tools are going to be successful while, in the long run, big pharma could be threatened b......
$1950

Amyotrophic Lateral Sclerosis: Opportunity Analysis and Forecast to 2027

Amyotrophic Lateral Sclerosis: Opportunity Analysis and Forecast to 2027 Summary Amyotrophic Lateral Sclerosis (ALS) is a motor neuron degenerative disease which affects both upper motor neurons (UMN) and lower motor neurons (LMN). It is a progressive disease, with patients becoming increasingly dependent on carers and physicians as time from onset increases, and ultimately, it is fatal. ALS can be split into two origins, hereditary - which is known as FALS (Familial ALS) or idiopathic - known as SALS (sporadic ALS). Currently there are only two drugs on the market that are approved for the treatment of ALS; Sanofi's Rilutek (riluzole) and Mitsubishi Tanabe Pharma's Radicava (edaravone). The drugs were special cases in terms of FDA approval, they did not meet the normal regulatory requi......
$10995

Multiple Sclerosis: Competitive Landscape to 2026

Multiple Sclerosis: Competitive Landscape to 2026 Summary Multiple Sclerosis (MS) is primarily considered an inflammatory demyelinating disorder of the CNS due to a dysfunctional immune system, leading to neurological disability1. The etiology of MS remains unknown; however, it is widely regarded as a complex interaction of genetic susceptibility, dysfunction of the immune system, and environmental factors. This report provides an assessment of the pipeline, clinical, and commercial landscape of MS. Overall, GlobalData expects that new drug approvals will expand the treatment options and drive MS market growth over the next decade (2016-2026). Scope This report combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the ......
$3495

Gene Therapy in CVMD

Gene Therapy in CVMD Summary Gene therapies have been a point of discussion during the last several years as a potential curative option for a variety of disease indications. While mainly still in preclinical stages, gene therapy aims to treat or alleviate a disease by genetically modifying the cells of a patient. This report focuses on gene therapies in development across the 8MM for cardiovascular and metabolic disorders, including coronary artery disease, critical limb ischemia, diabetic foot ulcers, and Pompe Disease. In addition, this report provides an assessment of the pipeline, clinical, and commercial landscape of gene therapies in CVMD supplemented with a variety of KOL and payer perspectives. Scope This report combines KOL and Payer insights along with data from the ......
$7995

Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2018

Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2018" provides an overview of Peripheral Neuropathy (Sensory Neuropathy) clinical trials scenario. This report provides top line data relating to the clinical trials on Peripheral Neuropathy (Sensory Neuropathy). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Tr......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy